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The emergence and spread of multi-drug resistant (MDR) especially carbapenem-
resistant Klebsiella pneumoniae is a major emerging threat to public health, leading
to excess in mortality rate as high as 50–86%. MDR K. pneumoniae manifests all
broad mechanisms of drug resistance, hence development of new drugs to treat
MDR K. pneumoniae infection has become a more relevant question in the scientific
community. In the present study a potential Streptomyces sp. ASK2 was isolated
from rhizosphere soil of medicinal plant. The multistep HPLC purification identified
the active principle exhibiting antagonistic activity against MDR K. pneumoniae. The
purified compound was found to be an aromatic compound with aliphatic side chain
molecule having a molecular weight of 444.43 Da. FT-IR showed the presence of OH
and C=O as functional groups. The bioactive compound was further evaluated for
drug induced toxicity and efficacy in adult zebrafish infection model. As this is the first
study on K. pneumoniae – zebrafish model, the infectious doses to manifest sub-clinical
and clinical infection were optimized. Furthermore, the virulence of K. pneumoniae in
planktonic and biofilm state was studied in zebrafish. The MTT assay of ex vivo culture of
zebrafish liver reveals non-toxic nature of the proposed ASK2 compound at an effective
dose. Moreover, significant increase in survival rate of infected zebrafish suggests that
ASK2 compound from a new strain of Streptomyces sp. was potent in mitigating MDR
K. pneumoniae infection.
Keywords: carbapenem resistant, MDR Klebsiella pneumoniae, zebrafish, Streptomyces sp. ASK2, bioactive
compound
INTRODUCTION
The emergence and spread of pathogens harboring extended spectrum β-lactamase-like
carbapenem-resistant Klebsiella pneumoniae (CR-KP), Escherichia coli, and other gram negative
bacteria are major emerging threat to public health (Schwaber and Carmeli, 2008; Vatopoulos,
2008). Of particular concern is the spread of multi-drug resistant (MDR) strains of K. pneumoniae,
an encapsulated opportunistic pathogen, colonizes the human gastrointestinal tract, skin,
nasopharynx and urinary tract. The pathogen is characterized by the presence of major virulence
Frontiers in Microbiology | www.frontiersin.org 1 April 2017 | Volume 8 | Article 614
fmicb-08-00614 April 10, 2017 Time: 12:30 # 2
Cheepurupalli et al. Klebsiella pneumoniae Zebrafish Infection Model
factors such as capsule (Siu et al., 2012), type 1 and type
3 pili (Di Martino et al., 2003), LPS (Vuotto et al., 2014) and
siderophores (Schembri et al., 2005). Among which, the thick
polysaccharide capsule is a promising virulence factor in
K. pneumoniae that facilitate its evasion of host defenses (Yu et al.,
2008). During infectious state, K. pneumoniae grow as a biofilm
on medical equipments like catheters and this is not only crucial
for the establishment of infection but also makes treatment
difficult (Zowawi et al., 2015). K. pneumoniae is the major cause
of infections in catheterized patients, and hence categorized as
one of the top eight significant nosocomial pathogens (Ullmann,
1998; Khan et al., 2015). Added to all, K. pneumoniae is
emerged as a new MDR varieties of human pathogens that
can have drastic consequences on health care worldwide (Patel
et al., 2008; Struelens et al., 2010; Ulu et al., 2015). One
such best example is the evolution and spread of CR-KP.
Extended spectrum β-lactamase (ESBL) and carbapenamase
producing K. pneumoniae have been shown to manifest all
broad mechanisms of drug resistance (Nordmann et al., 2009)
and also confer resistance to other class of antibiotics such
as aminoglycosides, sulphonamides, trimethoprim, tetracyclines,
and chloramphenicol, as the plasmids coding for ESBLs may
also carry additional genes conferring resistance to many other
antimicrobial classes (Rawat and Nair, 2010). Various drug
resistance mechanisms including gene mutation, acquisition of
novel antibiotic catalytic genes, modification of target site and
membrane proteins, differential expression of specific genes for
eﬄux pumps which mediate drug effects and biofilm formation
(Tenover, 2006; Nordmann et al., 2009; Cooksey, 2011). Hence
infections caused by CR-KP are hard to treat (Kumar et al., 2011;
Thakur et al., 2013). Currently, clinicians follow one of the three
strategies for the treatment of CR-KP, the first line antibiotic such
as meropenem, fluoroquinolone, and aminoglycoside. However,
at higher concentrations, these drugs are highly toxic. The second
choices of drugs are colistin, tigecycline, and fosfomycin, are
more toxic than the fist-line drugs (Melano et al., 2003; Petrosillo
et al., 2013).
Unfortunately, the emergence of colistin resistance limits
further treatment options leading to increase in mortality rates
to as high as 50–86% (Hirsch and Tam, 2010; Tzouvelekis et al.,
2012; Capone et al., 2013). The third approach, combination
therapy has been shown to be a promising choice to overcome the
emergence of drug resistance and minimizing drug toxic effect,
but in terms of outcomes there are very few reports illustrating
combination therapy in humans (Kontopidou et al., 2014). Hence
to combat the occurrence of resistant bacteria, development of
new antimicrobials has become a more relevant question in the
scientific community.
Rhizosphere soil of medicinal plants constitutes one such
source for exploring antimicrobials owing primarily to their
rich biodiversity (Khamna et al., 2009). Streptomyces spp. are
one such group of microbes with huge and untapped potential
for antimicrobial production. Thus many scientific communities
are exploring actinomycetes spp. from various habitats for the
development of novel anti-infectives. Rhizosphere soil are rich
source of microbes, as rhizodeposition provides an important
substrate for soil microbial community (Haichar et al., 2008),
especially medicinal plants due to their unique and enormously
divergent bioactive molecules. Hence, we have selected few
medicinal plants to isolate actinomycetes spp. antagonistic
against MDR K. pneumoniae.
During early stage of drug development, drug validation is
an important step. Zebrafish (Danio rerio) are widely accepted
model in the current decade for in vivo assessment of drug
efficacy (Kari et al., 2007). The major advantages of zebrafish as
a predictive model for assessing drug induced toxicity includes
the similarity of toxicity profiles to that of humans, requirement
of small amount of drug, simple route of administration and also
the efficacy of drug can be studied for different infectious dose (Li
and Hu, 2012).
In the present study, we have selected five different medicinal
plants to isolate potential Streptomyces sp. antagonistic against
MDR K. pneumoniae. The bioactive molecule was isolated by
multistep HPLC purification. The toxicity and efficacy of the
bioactive molecule were evaluated using adult zebrafish. Also we
optimized infectious dose to manifest sub-clinical and clinical
infections using planktonic and biofilm of K. pneumoniae. Even
though many zebrafish infectious models have been developed,
this is the first study to report K. pneumoniae – zebrafish model
and ex vivo organ culture of zebrafish liver to screen drug induced
toxicity.
MATERIALS AND METHODS
Screening of Multi-drug Resistance in
K. pneumoniae
Multi-drug resistant K. pneumoniae was obtained from
Department of Microbiology, Aravind Eye Hospital, Madurai,
India. The presumptive identification of the isolate was
done using HiCrome UTI agar (HiMedia, India). Further
identification were made by performing biochemical tests such
as Indole production, MR-VP test, urease test, and lactose
fermentation at 44.5◦C for 5 days (Ullmann, 1998; Podschun
et al., 2001).
Further, the strain was screened for drug resistance by
performing Kirby-Bauer disk diffusion test against various
selected antibiotics according to Clinical Laboratory Standards
Institute (CLSI) guidelines. The selected antibiotics cover a range
of β-lactams, fluoroquinolones, aminoglycosides, tetracyclines
and polypeptides. Commercially available antibiotics disks
(HiMedia, India) were used. The details of antibiotics used in the
present study are given in Table 1. Triplates were maintained and
the results were recorded as sensitive or resistant according to
CLSI standard chart.
Screening of ESBL Production
Double disk synergy method was performed to detect ESBL
production as recommended by CLSI (2011b). The method was
executed using cefotaxime (30 µg) alone and in combination
with clavulanic acid (10 µg). The cefotaxime disks were placed
30 mm apart from clavulanic–cefotaxime disk. The increase in
zone toward the disk of cefotaxime–clavulanate was considered
as positive for ESBL production (CLSI, 2011a; Kumar et al., 2014).
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TABLE 1 | Antimicrobial susceptibility pattern of clinical strain of
K. pneumoniae.
Antibiotic name Quantity of
antibiotic
Resistance/
sensitive/intermediate
β-lactums
I. Penicillins
Oxacillin 1 µg Resistance
Methicillin 5 µg Resistance
II. Cephalosporins
a. First generation antibiotics
Cefazolin 30 µg Resistance
Cefadroxil 30 µg Resistance
Cefalexin 30 µg Resistance
b. Second generation antibiotics
Cefuroxime 30 µg Resistance
c. Third generation antibiotics
Cefotaxime 30 µg Resistance
Ceftazidime 30 µg Resistance
Ceftazoxime 30 µg Resistance
d. Fourth generation antibiotics
Cefepime 30 µg Resistance
Cefazolin 30 µg Resistance
III. Carbapenems
Imipenem 10 µg Resistance
Meropenem 10 µg Resistance
Ertapenem 10 µg Resistance
Doripenem 10 µg Resistance
IV. Aminopenicillins
Amoxicillin 10 µg Resistance
Ampicillin 10 µg Resistance
Fluoroquinolones
Levofloxacin 5 µg Resistance
Gatifloxacin 5 µg Resistance
Moxifloxacin 5 µg Resistance
Ofloxacin 5 µg Resistance
Aminoglycosides
Gentamicin 30 µg Resistance
Tobramycin 10 µg Resistance
Amikacin 10 µg Sensitive
Tetracyclines
Tetracycline 30 µg Resistance
Polypeptides
Polymyxin B 300 units Sensitive
Rhizosphere Soil Collection and
Pretreatment
Rhizosphere soil of five different medicinal plants (Solanum
trilobatum, Ocimum tenuiflorum, Cardiospermum halicacabum,
Justicia adhatoda, and Wedelia chinensis) were collected from
local medicinal plant garden. The plants were removed with
intact roots and root zone soil were collected in a sterile container
and kept at 4◦C for further processing (Turnbull et al., 2012).
Ten gram of each soil samples was incubated at 60◦C for
40 min and re-suspended in 50 ml of saline. The re-suspended
mixture was diluted with 50 ml of saline containing 1.5% (v/v)
phenol and shaken for 30 min at 28◦C (Ramakrishnan et al.,
2009).
Isolation of Actinomycetes spp.
The actinomycetes spp. were isolated by serially diluting
the pretreated rhizosphere soil sample and inoculating by
spread plate method onto various agar medium recommended
for Actinomycetes spp. such as glycerol asparagine agar,
actinomycetes isolation agar (Nanjwade et al., 2010), tryptone
yeast extract medium (ISP1), yeast extract malt extract agar
(ISP2) (Busarakam et al., 2014) and Czapek dox agar (Mangamuri
et al., 2016). The media were supplemented with gentamicin
(1 µg/ml) and fluconazole (50 µg/ml) after sterilization to inhibit
the growth of bacteria and fungi, respectively (Eccleston et al.,
2008). The plates were then incubated for 21 days at 30◦C. All the
morphologically different actinomycetes sp. grown on different
agar medium were sub-cultured. Further, 20% of glycerol stocks
at−80◦C were maintained.
Antagonistic Activity against MDR
K. pneumoniae
Anti-bacterial activity of 51 actinomycetes isolates were assayed
to select a potential strain according to Ramakrishnan et al.
(2009). Spore suspensions of individual isolates were spot
inoculated (10 µl per spot) on Muller Hinton agar plates, and
incubated at 30◦C for 3 days. The cells were then killed with
chloroform vapors and were subsequently over laid with 15 ml
of medium containing 1% (w/v) agar, 0.5% (w/v) peptone, 0.5%
(w/v) yeast extract and inoculated with 100 µl of test isolate
MDR K. pneumoniae on the agar surface. The resulting clear
zone of inhibition (ZOI) was measured after 24 h of incubation.
The experiment was repeated thrice. Mean diameter of ZOI
and standard deviations were calculated. The strain ASK2 which
exhibited the antagonistic activity against MDR K. pneumoniae
was selected for taxonomical investigation.
Taxonomical Investigation of ASK2
Genomic DNA from Streptomyces sp. ASK2 was isolated using
the procedure described by Kimura (1980). The gene fragments
were amplified by using PCR Kit (GENEI Pvt. Ltd, India) and
the 16S rRNA gene was amplified using Mastercycler pro thermal
cycler (Eppendorf) with the following profile: initial denaturation
at 95◦C for 4 min, 30 amplification cycles of (95◦C for 1 min,
annealing temperature at 50◦C for 60 s, 72◦C for 1 min) and
a final extension step at 72◦C for 4 min. The PCR product
was electrophoresed and purified from 1.5% agarose gel using
QIAquick PCR purification kit (QIAGEN) and sequenced using
the primers 8F and U1492R (Abdel Azeiz et al., 2016). Sequencing
was done at Chromous Biotech, Bengaluru, India using ABI
3100 sequencer (Applied Biosystems). The sequence was edited
using FinchTV (Geospiza, Inc.) and BioEdit (Ibis Biosciences,
Abbott Labs). Sequence similarity search was made using 16S
rRNA gene and taxid specific BLAST tool. Representative 16S
rRNA sequences of related type strains of Streptomyces sp. were
retrieved from National Center for Biotechnology Information
(NCBI) database, and were aligned with Streptomyces sp.
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ASK2 using CLUSTAL-X software (Ser et al., 2015a). MEGA
version 5.2.2 neighbor-joining algorithm used to construct
phylogenetic tree (Tan et al., 2015). Kimura’s two-parameter
model was used to compute evolutionary distances for the
neighbor-joining algorithm (Ser et al., 2015b).
Fermentation and Recovery of
Biomolecules
The seed culture of ASK2 was grown on seed medium
(1% starch, 0.5% glucose, 0.5% yeast extract, 0.5% K2HPO4,
0.05% MgSO47H20) and incubated at 30◦C for 3 days on a rotary
shaker. 15% (v/v) of seed culture was used to seed 10 liters of
production medium (1% starch, 0.5% glucose, 0.5% yeast extract,
0.5% K2HPO4, 0.05% MgSO4 and 0.5% peptone) at 30◦C for
11 days. The fermented broth was centrifuged at 4300 × g for
10 min at 4◦C. The culture filtrate was extracted with equal
volume of ethyl acetate (EtOAc) and concentrated using rotary
vacuum evaporator. The EtOAc extract was further concentrated
in vacuo and dissolved in 10X phosphate buffer saline pH 7.0.
Purification
The EtoAc extract dissolved in phosphate buffer was purified
using Semi-preparatory HPLC (Agilent Technologies, India).
Reverse-phase analytical C18 column (Agilent Technologies,
Netherlands: 4.6 mm × 250 mm) was used for standardizing the
experimental conditions. The chromatographic separation was
carried out using C18 preparatory column (Agilent Technologies,
Netherlands: 10 mm× 250 mm) with water and methanol, 60:40,
flow rate of 4 ml/min and injection volume of 0.5 ml. The elution
pattern was monitored at 250 nm, peaks were then eluted out
separately and each of them was screened for bioactivity by means
of broth dilution method. The broth system consisted of 30 µl of
0.5 McFarland of K. pneumoniae culture in 2 ml nutrient broth
with 200 µl of purified compound. The similar protocol was
followed to find the activity against the standard isolate obtained
from Microbial culture collection, Pune, MCC 2570-Klebsiella
pneumoniae, NDM type drug resistant strain.
The fraction which displayed antimicrobial activity was
further processed for second and third step purification by using
water and methanol (40:60) as a mobile phase.
Characterization
Fourier Transform–infra-red Spectroscopy
The HPLC purified ASK2 was studied by Fourier transform–
infra-red spectroscopy and the characteristics bands between
4000 and 400 cm−1 were recorded using Perkin Elmer, Spectrum
RX I.
Mass Spectroscopy Analysis
The purified compound was subjected to Electron Spray
Ionization and the molecular weight was determined from m/z
values.
1H-NMR
The purified ASK2 was dissolved in DMSO and spectral analysis
was performed using BRUCKER 300MHz AVANCE-II.
MIC Determination
The MIC of the compound ASK2 against K. pneumoniae
was determined for the active fraction using microbroth
dilution assay as described in the CLSI protocols. The
overnight K. pneumoniae culture was diluted to obtain the final
concentration of 105 cfu/ml. The compound was dissolved in PBS
and was tested at concentrations from 0.5 to 64 µg in twofold
step intervals. Each well contains 100 µl of nutrient broth, 10 µl
of culture and 100 µl of compound with varying concentrations.
Triplicates were maintained for each concentration. The OD
values were recorded at 600 nm, as well, the colony counts were
recorded on Nutrient agar plates. The OD values and colony
forming units were used to determine the MIC.
Animals
Zebrafish (D. rerio) irrespective of sex measuring approximately
4 to 5 cm in length, and weighing 300 mg, were purchased from
a local aquarium. Proper care and maintenance such as feed,
aeration and 14:10-h light/dark cycle at 25◦C were ensured to
allow acclimatization for a week before the study. All experiments
were performed in compliance with applicable national and/or
institutional guidelines for the care and use of animals (Animal
Biosafety Level 2) were followed.
Preparation of Different Concentration of
K. pneumoniae
Klebsiella pneumoniae were grown overnight in nutrient broth
at 37◦C. Different concentrations of cells were prepared by
observing optical density and by plating on solid media ranging
from 104 to 1014 cfu/ml.
Biofilm Formation
A loopful of K. pneumoniae cells were inoculated in 50 ml
nutrient broth and incubated at 37◦C for 18 h. The cells
were collected by centrifugation and adjust to 0.5 McFarland
(108 cfu/ml) with nutrient broth. 500 µl of inoculum were added
to wells of 6 well cell culture plates containing glass coverslip of
1 cm2and incubated at 37◦C for 72 h. The media were discarded
and non-adherent cells were removed by washing with PBS. The
biofilms that remained over the coverslips were scrapped and
suspended in PBS and optical density of biofilm was measured
at OD600.
Induction of K. pneumoniae Planktonic
and Biofilm Infection
To establish K. pneumoniae infection in zebrafish, planktonic
cells of different density (104–1014 cfu/ml) and biofilm
(109–1014 cfu/ml) were used. Each test group (n = 5 for each
group) were infected by injecting 10 µl of different density of
planktonic cells of intramuscularly 45◦ angle to the spine into
a position immediately lateral to the Dorsal fin at a depth of
2 mm using sterile 1 ml insulin syringe (U-40, 0.30 mm× 8 mm).
One uninfected group was maintained as control. The fish were
observed daily to monitor pathological changes such as infection
and lethality. The fish which were alive were sacrificed after
24 h and the dead fish were dissected immediately (∼6 hpi).
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The selected infected and uninfected whole fish were placed on
iced wax plate, the organs were dissected out and the muscle
tissue was used to estimate K. pneumoniae loads in. 100 mg of
dissected muscle tissue were placed in a 2 ml microcentrifuge tube
and homogenized using micropestle in 0.5 ml phosphate buffer
saline and made upto 1 ml. This was followed by serial dilutions
of 10−1 to 10−5 homogenates using sterile PBS and counts of blue
mucoid colonies were estimated on UTI agar medium using 10−5
dilution. The colonies were counted following 24 h incubation at
37◦C.
Toxicity Assessment
The compound was dissolved in phosphate buffer (10X) and fixed
dose procedure was followed to assess the non-lethal toxicity.
The following concentrations of compound were evaluated
(8, 16, 32, 64, and 128 µg/ml). Zebrafish were challenged with
intramuscular injection of 10 µl of different doses of compound
(n = 5), and control groups received phosphate buffer as vehicle
control (n= 5). Zebrafish were monitored for behavioral changes
and mortality for upto 120 h. The experiments were repeated
thrice on three independent days.
Ex Vivo Culture of Liver and Cell Viability
Assay
Liver toxicity assay were performed for low dose (24 µg/ml),
effective dose (48 µg/ml), and high dose (128 µg/ml) of ASK2.
Effective dose is the one that was sufficient to achieve the
desired clinical improvement (survival) after being challenged
with infectious dose of K. pneumoniae cells. The toxicity was
evaluated by MTT cell viability assay in ex vivo organ culture
of zebrafish liver. The protocol developed for hepatotoxicity
assessment in ex vivo organ culture of zebrafish is provided in
Figure 1.
Each test group (n = 5) was administered with 24, 48, and
128µg/ml of drug concentrations, and the control group received
PBS. After 12 h, the fish were anesthetized by 150 mM of tricaine-
S (MS-222) and euthanized by decapitation, the liver was isolated
and washed thrice with PBS (experiment was carried at 4◦C).
The cleaned and chilled liver was trypsinized for 5 min to obtain
single cells. To allow cell adherence, trypsin was then neutralized
with culture media (DMEM + 10% FCS + 1X antibiotics).
The dissociated cells were centrifuged (43 × g for 5 min) at
4◦C and the cell pellets were re-suspended in growth media.
The cells were seeded in a 96 well flat bottom microtitre plate
at a density of 104 cells/ml with 100 µl of culture medium.
A control well (culture medium alone) was maintained. The
plate was incubated at 37◦C for 12 h to allow the liver cells
to grow and adhere. After incubation, the medium from the
wells were removed carefully and MTT assay was performed.
Briefly, 10 µl of MTT solution was added and the plates were
incubated for 4 h at 28◦C. At the end of the incubation, the
culture medium was removed and 100 µl of DMSO was added
and allowed to react for 45 s. The readings were obtained at
570 nm using ELISA plate reader. Meanwhile, the viability of
cells were also assessed using fluorescent microscopy using FITC
and propidium iodide stain to discriminate live and dead cells.
After the removal of cell culture medium, the staining solution
was added and allowed to stain for 15 min in dark. The staining
solution was removed by washing with PBS and the samples were
analyzed using Nikon Trinocular microscope (Nikon Eclipse
Ni-U, Japan).
Histopathology
Selected whole zebrafish were fixed following wash with 0.9%
ice-cold saline and fixed immediately by immersion in Dietrich’s
fixative (10 ml per fish), with overnight incubation at room
temperature. Fixed samples were routinely processed and then
embedded in paraffin; 5 mM thick longitudinal sections were
prepared which were de-waxed and rehydrated by standard
methods and stained by haematoxylin and eosin. The histological
observation of muscle tissue were made using Nikon Trinocular
microscope (Nikon Eclipse Ni-U, Japan).
Efficacy of Compound to Treat MDR
K. pneumoniae Infection
Two groups of fish were infected with 10 µl of 1012 cells
intramuscularly. After 3 h of infection, the treatment group
(n = 20) were intramuscularly administered with effective dose
(48 µg/10 µl) of ASK2. The control group received sterile
PBS as vehicle control. All the groups were monitored for the
behavioral changes and mortality for 120 h. The survival rate and
K. pneumoniae burden were recorded.
Statistical Analysis
All experiments were performed in triplicates. Mean, Standard
deviation and Student’s t-test was performed to test the statistical
significance in MTT assay studies and graphs were prepared by
using Graphpad prism 6.
RESULTS
Screening of Multi-drug Resistance in
K. pneumoniae
Presumptive identification of K. pneumoniae using chromogenic
agar results in the formation of blue mucoid colonies (Rajaratnam
et al., 2014). Further, the use of conventional phenotypic methods
allowed the characterization of K. pneumoniae as mucoid, non-
motile, encapsulated isolate exhibiting positive reactions for
VP test, urease test, lactose fermentation at 45◦C and Indole
negative, which basically distinguish it from K. oxytoca (Brisse
et al., 2006; Patel et al., 2008). The antimicrobial susceptibility
of K. pneumoniae against various antibiotics are given in
Table 1. It was observed that the clinical K. pneumoniae
exhibits resistance to all antibiotics of different classes including
β-lactams, fluoroquinolones, aminoglycosides, tetracyclines and
polypeptides and shows sensitivity to polymyxins alone. Further,
the test strain shows positive for ESBL screening using
cefotaxime–clavulanate combined disk test as recommended by
CLSI. The test strain showed 25 mm of ZOI for cefotaxime-
clavulanate combined disk (30/10 µg) whereas absence of ZOI
was observed for cefotaxime disk. This result confirms that the
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FIGURE 1 | Schematic overview of ex vivo organ culture of zebrafish liver cells. Step I: Acclimatization of zebrafish for 1 week; Step II: Injected with different
concentrations of ASK2 and observe for 6 h; Step II: Separation and trypsinization of liver; Step IV: Plating of liver cells in 96 well plate for over night and checking
cell viability by MTT assay.
clinical strain K. pneumoniae used in the present study produces
ESBL. Hence the clinical strain was designated as MDR bacteria
as per ECDC and CDC standard definition (Magiorakos et al.,
2011).
Anti CR-KP Activity and Taxonomical
Characterization of Potential Isolate
During the study, 51 morphologically different actinomycetes
spp. were isolated from rhizosphere soil of five different medicinal
plants. However, only one isolate was shown to have a potential
activity against MDR K. pneumoniae. The isolate Streptomyces sp.
ASK2 obtained from Solanum trilobatum soil sample displayed
promising antagonistic activity with ZOI of 33 ± 0.5 mm
by colony over lay assay (Figure 2B). Similarly the culture
supernatant exhibited strongest activity against drug resistant
K. pneumoniae and thus the strain ASK2 was subjected for
taxonomical studies. The strain ASK2 was characterized by
wrinkled, rough, irregular, dry and white aerial mycelia on ISP2
agar medium (Figure 2A). The scanning electron micrograph
of ASK2 was found to have branched ribbon like spores with
smooth surface (Figure 2C). The sequence (1053 base sequences)
similarity search using BLAST tool reveals that ASK2 (Gen
Bank Accession Number: KR187109) belongs to a distinct
phyletic line in Streptomyces sp. The isolate was closely related
to the type strain of S. rimosus subsp. paromomycinus strain
NBRC 15454 sharing a homology of 97%. On the basis of
cultural characteristics, spore structural properties, and 16S
rRNA sequence, ASK2 was identified as a new strain belonging
to Streptomyces sp. (Figure 3). The evolutionary history was
inferred using the Neighbor-Joining method (Saitou and Nei,
1987; Ser et al., 2016). The optimal tree with sum of branch
length = 0.04392832 was shown. The percentage of replicate
trees in which the associated taxa clustered together in the
bootstrap test (1000 replicates) were shown next to the branches
(Felsenstein, 1985). The tree was drawn to scale, with branch
lengths in the same units as those of the evolutionary distances
used to infer the phylogenetic tree. The evolutionary distances
were computed using the Kimura 2-parameter method (Kimura,
1980) and were in the units of the number of base substitutions
per site. The rate variation among sites was modeled with
a gamma distribution (shape parameter = 10). The analysis
involved nucleotide sequences of 20 Streptomyces sp. All
ambiguous positions were removed for each sequence pair. There
were a total of 1520 positions in the final dataset. Evolutionary
analyses were conducted using MEGA5 (Tamura et al., 2011).
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FIGURE 2 | (A) Colony morphology of Streptomyces sp. ASK2 on ISP2 agar medium; (B) Antagonistic activity against K. pneumoniae by colony overlay assay;
(C) Scanning electron micrograph of Streptomyces sp. ASK2 displaying branched ribbon like spores with smooth surface.
FIGURE 3 | Neighbor-joining phylogenetic tree based on 16S rRNA gene sequences showing the relationship between Streptomyces sp. ASK2 and
representatives of related species.
Multistep Purification and Identification
of Active Peak
To isolate the active component, the crude extract (3 g) was
subjected to reverse phase HPLC using optimized experimental
parameters. Among the 12 fractions collected, the 3rd fraction
with a retention time of 4.57 min showed potential antibacterial
activity using broth dilution method. The re-passage of the
active peak over the same column under the same experimental
conditions yielded three peaks, among which one prominent
peak at a retention time of 4.4 min was found to have bioactivity
against K. pneumoniae. The compound purity obtained at
the second re-passage was 86%. Hence the active peak was
subjected to third round of re-passage with 40% water and 60%
methanol solvent system. The compound purity was increased
to 93% (Supplementary Image S1). The compound showed the
killing effect on standard NDM type K. pneumoniae. The pure
compound obtained was white solids and are soluble in H2O,
DMSO, methanol and insoluble in CDCl3 and petroleum ether.
Frontiers in Microbiology | www.frontiersin.org 7 April 2017 | Volume 8 | Article 614
fmicb-08-00614 April 10, 2017 Time: 12:30 # 8
Cheepurupalli et al. Klebsiella pneumoniae Zebrafish Infection Model
FIGURE 4 | Characterization of purified ASK2 bioactive molecule from Streptomyces sp. ASK2: (A) FT-IR Spectra: Presence of strong absorption troughs at
3400 cm-1 (∗∗) and 1651 cm-1 (∗) representing the presence of OH and C=O groups; (B) ESI-MS spectra; (C) 1H NMR spectra represents the presence of aromatic
compounds (#) and presence of hydrogen in aliphatic carbon chain (##).
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In order to verify whether the compound is similar to that
produced by S. rimosus, the HPLC comparison of ASK2 and
oxytetracycline were made. HPLC comparison of oxytetracycline
and ASK2 does not appear to have similar separation profile.
Moreover, the FT-IR spectrum of oxytetracycline and ASK2
were different. IR spectrum of ASK2 showed strong absorption
troughs at 3400 and 1651 cm−1 that represents the presence
of OH and C=O groups, respectively (Figure 4A). Whereas,
primary amine is the main functional groups in oxytetracycline,
the ASK2 did not show any absorption peaks for primary amine
(two peaks at ≈3400 cm−1 and ≈3500 cm−1), (Ramasamy
et al., 2014). ESI MS data reveals that the molecular weight
of ASK2 is found to be 444.43 Da (Figure 4B), which was
found to be differing from oxytetracycline (460.43 Da) (Singh
et al., 2011). In addition the 1H NMR showed the triplet peaks
at 6.944 to 7.249 ppm. It indicates the presence of hydrogen
moiety in aromatic environment. Peaks in the range of 1.199 to
1.313 ppm indicate the presence of aliphatic nature of carbon
chain (Figure 4C). Hence the bioactive compound isolated from
Streptomyces sp. ASK2 is warrant to be a new compound,
however, other NMR spectrometric methods are required to
elucidate the complete structural details of the compound.
Screening of Toxicity and Efficacy of
ASK2 in Zebrafish Model
Prior to testing of compound, the MIC of ASK2 was estimated
for the purified compound. 16 µg/mL was found to be the MIC.
The agar plates were recorded for the absence of colonies at
this concentration. And the OD600 was comparable with the
control (Nutrient broth+ compound) for final concentrations of
16 µg/mL and above.
Optimization of Subclinical and Clinical
Infection for Planktonic Cells
We examined the susceptibility of zebrafish to K. pneumoniae.
The adult fish were injected intramuscularly with various
infectious dose (104–1014 cfu/ml) to induce subclinical and
clinical infection in zebrafish. The survival rate of each infectious
dose is given in Table 2. Upon infection with 1014 and
1012 cfu/ml, zebrafish readily became infected displaying 100%
mortality within 24 and 120 h, respectively. Whereas, upon
infection with less than 1012 cfu/ ml, zebrafish were active
and no mortality was observed (Table 2). Even though the
aquarium water was highly loaded with K. pneumoniae, cells
less than 1012 cfu/ml does not lead to clinical symptoms,
suggesting that intramuscular injection with optimum dosage
of K. pneumoniae are crucial to enhance the intracellular
invasion and spread. Further, the estimation of colony forming
units from tissue homogenates of the infected fish of each
group on UTI agar reveals the presence of large numbers
of K. pneumoniae organisms. These results demonstrated
that K. pneumoniae successfully infects zebrafish and cause
clinical illness. K. pneumoniae is considered to be the most
important histamine producing bacteria in fish (Kanki et al.,
2002). It is also known to cause fin and tail disease in
Rainbow trout and more reports on Klebsiella infection
in different fishes are documented (Diana and Manjulatha,
2012).
Virulence of K. pneumoniae Planktonic
and Biofilm
The role of different phenotypic expression (planktonic and
biofilm) of K. pneumoniae were examined in zebrafish free
living and biofilm model. Adult zebrafish were challenged
with different concentrations of K. pneumoniae in planktonic
and biofilm state. Biofilm at the dose of 1012 cells, caused a
significant clinical symptoms and 100% mortality within 120 h.
The lower dose (<1012 cfu/ml) leads to sub-clinical infection
alone. These observations were similar to that of planktonic
cells. Furthermore, the colony counts of tissue homogenate were
similar to that of planktonic cells. The results show no correlation
between severity of infection and different phenotypes of
K. pneumoniae in zebrafish planktonic and biofilm infection
model (Table 3).
Toxicity Assessment by Fixed Dose
Procedure
To assess the non-lethal toxicity, various concentrations of
ASK2 were evaluated. Zebrafish challenged with different
concentrations were observed for behavioral changes and
mortality for upto 120 h. The compound was non-lethal
upto 64 µg/ml concentration, whereas doses greater than
64 µg/ml was toxic, and 100% mortality were observed for
128 µg/ml (Table 4). However, to screen for liver toxicity,
the low dose (24 µg/ml), effective dose (48 µg/ml) and high
dose (128 µg/ml) of ASK2 were evaluated by performing
MTT reduction assay, fluorescent microscopic technique, and
histopathology.
Hepatotoxicity Assessment in Ex Vivo
Culture of Zebrafish Liver
To evaluate cytotoxic activity of ASK2, the zebrafish were
challenged with either low dose, effective dose or high dose of
the compound. The treated and control groups were sacrificed
after 7 h exposure and liver was obtained. The liver were carefully
washed, trypsinized and grown in cell culture medium and
incubated for 12 h. After the incubation period, the monolayer
cultures were checked for cross contamination and light
microscopic examination revealed the presence of adherent liver
cells in microtitre plate. The cell viability by MTT assay displays
that the compound induced hepatotoxicity in a concentration
dependent manner (Figure 5). Zebrafish challenged with 24,
48, and 128 µg/ml compound shows 94, 83, and 61% relative
cell viability, respectively (Figure 5). In addition, the florescent
microscopic image depicts the toxicity by discriminating dead
cells and viable cells. The effective dose (48 µg/ml) was
found to have more viable cells (Figure 6B) similar to control
(Figure 6A) compared to high dose (128 µg/ml) (Figure 6C).
The statistical significance by Student’s t-test for 24 µg/ml
was p = 0.0337, 48 µg/ml; p = 0.0040 and 128 µg/ml;
p= 0.0003.
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TABLE 2 | Optimization of infectious dose of K. pneumoniae in zebrafish (planktonic cells).
Dose of challenge Type of infection Klebsiella burden in muscle cultured on UTI agar medium Survival rate (%)
24 hpi 48 hpi 72 hpi 96 hpi 120 hpi
104 cfu/ml Sub-clinical 1 ± 0.5 × 105 cfu/ml 100 100 100 100 100
106 cfu/ml Sub-clinical 2 ± 0.4 × 106 cfu/ml 100 100 100 100 100
108 cfu/ml Sub-clinical 2.6 ± 0.3 × 106 cfu/ml 100 100 100 100 100
1010 cfu/ml Sub-clinical 2.8 ± 0.3 × 106 cfu/ml 100 100 100 100 100
1012 cfu/ml Clinical 3.8 ± 0.6 × 106 cfu/ml 90 50 35 30 0
1014 cfu/ml Clinical 3.2 + 0.7 × 107 cfu/ml 0 0 0 0 0
Experiment was repeated thrice on three independent days, n = 5.
TABLE 3 | Effect of biofilms of K. pneumoniae in zebrafish (Biofilm).
Bacterial inoculums Klebsiella burden in muscle Survival rate (%)
24 hpi 48 hpi 72 hpi 96 hpi 120 hpi
108 cfu/ml 2.3 ± 0.5 × 106 cfu/ml 100 100 100 100 100
1010 cfu/ml 2.8 ± 0.4 × 106 cfu/ml 100 100 100 100 100
1012 cfu/ml 3.9 ± 0.7 × 106 cfu/ml 85 50 40 35 0
Experiment was repeated one time on three independent days, n = 5.
Histopathology
A histopathological analysis of muscle after injection of the ASK2
compound was performed to check for toxicity of the compound.
As can be seen from Figure 6, exposure of zebrafish to ASK2
compound at a concentration of 48 µg/ml (Figure 6E) did not
produce any adverse change in the muscle, the site of injection of
the compound. The muscle showed normal morphology as that
observed with the control fish (Figure 6D). However, in the case
of zebrafish that were exposed to the compound at a higher dose,
128 µg/ml (Figure 6F), there were focal points of cell infiltration
into the muscle but the overall morphology of the muscle in this
case also appeared to be normal. This suggests that the compound
ASK2 is not toxic at the effective dose of 48 µg/ml, used to treat
Klebsiella infection.
Efficacy of Compound to Treat Klebsiella
Infection
Injection of 1012 cfu/ml of Klebsiella inoculum to the healthy
adult fish showed clinical infection and 100% mortality within
120 h. Whereas, 90% of survival rate were observed for the
treatment group after being treated with 48 µg/ml of ASK2
compound. Also, there was visible reduction in Klebsiella burden
TABLE 4 | In vivo toxicity of different concentrations of compound (n = 5).
Concentration
of compound
(µg/ml)
Survival rate (%)
24 h 48 h 72 h 96 h 120 h
8 100 100 100 100 100
16 100 100 100 100 100
32 100 100 100 100 100
64 100 60 60 60 60
128 20 0 0 0 0
FIGURE 5 | MTT assay of zebrafish liver cells in ex vivo conditions.
Student’s t-test was performed to each treated group comparing with control.
24 µg/ml (∗p = 0.0337), 48 µg/ml (∗∗p = 0.0040), 128 µg/ml (∗∗∗p = 0.0003).
after 24 hpi in zebrafish treated with effective dose of ASK2
compound (Figure 7). The significant increase in survival rate
at intermediate concentration clearly indicates that ASK2 exerts
a potential therapeutic effect by controlling K. pneumoniae
proliferation.
DISCUSSION
As the burden of MDR K. pneumoniae is growing rapidly,
discovery of new drugs is an indispensable process to combat
those emerging resistant pathogens (Bérdy, 2012). Actinomycetes
are still the promising candidates for the discovery of novel
antibiotics which are being isolated from wide range of natural
habitats (Tiwari and Gupta, 2012). Exploring the untapped
region for collection of rare and novel microbial species is
Frontiers in Microbiology | www.frontiersin.org 10 April 2017 | Volume 8 | Article 614
fmicb-08-00614 April 10, 2017 Time: 12:30 # 11
Cheepurupalli et al. Klebsiella pneumoniae Zebrafish Infection Model
FIGURE 6 | Fluorescent Microscopic images of liver cells and Histopathology of zebrafish muscle after exposure to ASK2 compound: Liver cell
viability by fluorescence microscopy, (A) Control; (B) Treatment with 48 µg/ml ASK2; (C) Treatment with 128 µg/ml ; Muscle tissue histopathology; (D) Control;
(E) Treatment with 48 µg/ml ASK2; (F) Treatment with 128 µg/ml (Arrows point to cellular infiltration in muscle, possibly owing to toxicity of the compound).
However, no such changes were seen in Control and; (E) muscle tissue histopathology.
FIGURE 7 | Efficacy studies of ASK2 in in vivo conditions: Treated
group was showing 90% survival up to 120 h, where as 100% mortality
was observed within 120 h in untreated group compared to control
group.
challenging for the exploration of novel drugs (Cragg and
Newman, 2013). However, we believe that potential antibiotics
producers are still hidden in very familiar sources like soil,
plants, marine plant and animals etc. Rhizosphere soil of
medicinal plants are one such striking source of diverse microbial
community (Köberl et al., 2013). In the present study, 51 different
actinomycetes spp. were isolated from rhizosphere soil of five
different medicinal plants. Streptomyces sp. ASK2 isolated from
Solanum trilobatum was found to have a potential inhibitory
activity against MDR K. pneumoniae. Solanum trilobatum is an
important plant in medicine with wide applications including
treatment of respiratory diseases, tuberculosis, cardiac and liver
infection. It is also familiar for anti-inflammatory, anti-oxidant
and immunostimulatory properties (Priya and Chellaram, 2014;
Venugopal et al., 2014).
Streptomyces rimosus is well-known for the synthesis of
oxytetracycline, possessing broad spectrum antibacterial activity
and some bacterial strains have developed resistance (Chopra and
Roberts, 2001). However, the usage of oxytetracycline for humans
is prohibited as it is associated with adverse toxic effects. Hence
it is now generally used to treat rickettsiae and mycoplasma
infection in animals (Stuen and Longbottom, 2011).
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The significance of toxicological screening are well recognized
as an important step in drug development process, hence several
zebrafish models and assays have been developed to study drug
toxicology this decade (Bhusnure, 2015). In the current report,
we have modeled K. pneumoniae infection in adult zebrafish, to
study toxicity and efficacy of ASK2 isolated from Streptomyces sp.
ASK2.
Since there are no reports on K. pneumoniae zebrafish
infection model, we decided to optimize infectious dose,
which are quite varied with strain, host susceptibility and
even the route of transmission. Sub-clinical and clinical
infections were established with infectious dose of 104–
1010 and 1012–1014 cfu/ml, respectively (Table 2). A similar
kind of observation was recorded for E. faecalis in a dose-
dependent manner in zebrafish larvae. In general, most of
the studies with zebrafish embryo and early larvae used
bacterial density of 103–108 cfu/ml to study host pathogen
interactions and to predict drug safety. However, the
infectious dose and pathogenicity are varied with pathogens
belonging to same species of different strains. For instance,
in Galleria mellonella infection model, Wand et al. (2013),
demonstrated that different strains of K. pneumoniae showed
different virulent expression. And another study revealed
that different strain of same species can exhibit different
degree of pathogenicity in vivo model (Lavender et al.,
2004).
Though several zebrafish infectious models have been
developed (Neely et al., 2002), the effect of drug to treat
biofilm related infections are very limited using zebrafish (Chu
et al., 2014). Infact, many studies have suggested that biofilm
formation is an important phase in the infective process.
Therefore, we investigated the significant role of planktonic and
biofilm state of K. pneumoniae to cause infection. In our study,
K. pneumoniae biofilm being formed in vitro were analyzed
for its virulence in zebrafish. We observed a similar kind of
pathological consequences in zebrafish planktonic and biofilm
model. The infectious dose, severity of illness, survival rates and
bacterial counts in muscle homogenates were similar for biofilm
and planktonic zebrafish infection models (Tables 2, 3). One
possible reason for similar pathological observation is the gene
expression for biofilm formation on solid support is different
from those required to establish in vivo (Lavender et al., 2004).
Many studies have explored biofilm formation as a virulence
phenotype in majority of the bacteria. For example, in a study
with Streptococcus suis zebrafish model, S. suis biofilm had LD50
values greater than the LD50 values of planktonic cells, the
virulence of biofilm cells were weaker than planktonic cells
(Wang et al., 2011). However, in our case, the pathological
consequences are similar for planktonic and biofilms. Our result
suggests that biofilm state of the pathogens is not exclusively
required for virulence expression. However, screening of biofilm
establishment in zebrafish and validating with different strains of
K. pneumoniae are essential to confirm our findings which is our
lab’s future focus.
Once the infectious doses were optimized, we investigated
the efficacy of ASK2 compound and toxicity in adult zebrafish,
because drug induced liver injury is a major toxicological
problem. The similarity of zebrafish liver functions and drug
metabolism to that of humans, zebrafish has been used as good
model for drug toxicity (Triebskorn et al., 2004; Zodrow et al.,
2004; Devi et al., 2015; Ayaz Ahmed et al., 2016; Lowrence et al.,
2016). The most commonly used drug induced hepatotoxicity
assay in laboratory animals includes serum enzyme assay and
histological assay (McGrath and Li, 2008). The present study
assessed the liver injury by measuring MTT reduction to
determine the cell viability for ex vivo culture of liver. There
were no obvious changes in liver cell viability and metabolic
activity, during ex vivo culture of liver from healthy adult
zebrafish. The cytotoxic effect of ASK2 was observed in a dose
dependent manner in zebrafish. The effective dose (48 µg/ml)
of ASK2 displayed 83% liver cell viability, similarly no mortality
were recorded during in vivo toxicity study. However, 61% liver
damage within 6 h was recorded for treatment group with high
dose (128 µg/ml), that is at eightfold of MIC and at the same
point, 100% mortality were recorded within 24 h. The results of
ex vivo culture of liver toxicity are highly co-related with in vivo
toxicity and histopathology analysis, suggesting that ex vivo
culture of zebrafish liver are a highly reliable and reproducible
method for the assessment of drug induced toxicity. In an earlier
study, zebrafish brain was similarly cultured ex vivo to study the
effects of ethanol and acetaldehyde (Zenki et al., 2014).
The efficiency of drug to treat infected zebrafish showed that
ASK2 compound was highly effective in killing and controlling
K. pneumoniae proliferation. The obvious reduction of 1012 to
104 cfu/ml bacterial burden was recorded with an improvement
of 90% survival rate. The efficiency of the compound was
highly comparable with untreated group which showed 100%
mortality at 120 hpi (Figure 7). Hence, ASK2 compound isolated
from Streptomyces sp. ASK2 was shown to be effective for the
management of MDR K. pneumoniae infection in zebrafish
model.
CONCLUSION
The continuous use of similar kind of drugs for treatment and
overuse of antibiotics in both human and livestock induces
different drug resistance mechanisms in bacteria. Since there
are no novel antibiotics in drug development in the present
century for carbapenemase producing enterobacteriaceae, the
existing antibiotics have re-emerged for current medications.
Hence in response to address these issues the present research
has come up with a potential anti-MDR K. pneumoniae molecule
from Streptomyces sp. ASK2. The antibacterial compound ASK2
reported in the present study was shown to control MDR
K. pneumoniae infection in zebrafish infection model with
a significant improvement in fish survival rate. Furthermore,
the in vivo toxicity, MTT assay of ex vivo liver culture, and
histopathology results strongly support the non-toxic property of
ASK2 at effective dose. These findings support the potentiality of
ASK2 to treat MDR K. pneumoniae infection in zebrafish model.
Further investigations on complete structural elucidation and
extensive evaluation of chronic toxicity may lead to a novel drug
candidate to combat the persistent MDR K. pneumoniae.
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